English
Home > Products > CAS NO 136705-66-3

China CAS NO 136705-66-3 Factory

To be a result of ours specialty and service consciousness, our enterprise has won an excellent status between buyers all around the globe for CAS NO 136705-66-3,136705-66-3,(3S,6S)-(+)-3,6-Octanediol,3,6-Octanediol, If possible, be sure to send your needs with a detailed list including the style/item and quantity you require. We will then deliver our greatest price ranges to you.
CAS NO 136705-66-3, Our company promises: reasonable prices, short production time and satisfactory after-sales service, we also welcome you to visit our factory at any time you want. Wish we now have a pleasant and long terms business together!!!

Related Products

Hot Products

  • Calcobutrol

    Calcobutrol

    Product Name:Calcobutrol
    Molecular Formula:C18H36CaN4O9
    Molecular Weight:492.58
    CAS Registry Number:151878-23-8
  • Tosufloxacin tosilate

    Tosufloxacin tosilate

    Product Name:Tosufloxacin tosilate
    Molecular Formula:C19H17F3N4O4
    Molecular Weight;422.36
    CAS Registry Number;107097-79-0
  • (+/-)-trans-1,2-Diaminocyclohexane

    (+/-)-trans-1,2-Diaminocyclohexane

    Product Name:(+/-)-trans-1,2-Diaminocyclohexane
    Molecular Formula:C6H14N2
    Molecular Weight:114.19
    CAS Registry Number:1121-22-8
  • 2-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

    2-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

    Product Name:2-fluoro-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
    Molecular Formula:C11H15BFNO2
    Molecular Weight:223.05
    CAS Registry Number:444120-95-0
  • Asciminib hydrochloride

    Asciminib hydrochloride

    Product Name:Asciminib hydrochloride
    Molecular Formula:C20H18ClF2N5O3. HCl
    Molecular Weight;486.3
    CAS Registry Number;2119669-71-3
  • Arabinofuranosyluracil

    Arabinofuranosyluracil

    Product Name:Arabinofuranosyluracil
    Molecular Formula:C9H12N2O6
    Molecular Weight:244.2
    CAS Registry Number:3083-77-0
  • Related Blog
  • Reviews

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept